Retraction

Phillygenin Exerts In Vitro and In Vivo Antitumor Effects in Drug-Resistant Human Esophageal Cancer Cells by Inducing Mitochondrial-Mediated Apoptosis, ROS Generation, and Inhibition of the Nuclear Factor kappa B NF-κB Signalling Pathway

Paper Information

Record ID:

43058

Author(s):

Jiantao He
Wei Wei
Qingbo Yang
Yiling Wang

Journal:

Medical Science Monitor: International Medical Journal of Experimental and Clinical Research ( International Scientific Information, Inc )

Publication Date:

January 25, 2019

Retraction Date:

March 25, 2021 (4.7 years years ago)

Subjects:

Broad Categories:
Medicine Biology Genetics

Specific Fields:
Biology - Cellular Genetics Medicine - Gastroenterology Medicine - Oncology

Institutions:

Country:

🇨🇳 China

Article Type:

Research Article

Publisher:

International Scientific Information, Inc

Open Access:

Yes

DOI:

10.12659/MSM.913138

PubMed ID:

30681987

Retraction PubMed ID:

3376255

Retraction Details

Retraction Reasons:

Nature of Retraction:

Retraction

Retraction Notice:

10.12659/MSM.932333

Additional Notes:

See also: https://pubpeer.com/publications/4282EF797C611BE814A88BA1D6E519

Citations (21)

21

Total Citations

14

Post-Retraction
(66.7%)

6

Pre-Retraction

1

Same Day

Post-Retraction Citation Analysis

1 Within 30 days

9 Within 1 year

2 After 2+ years

1140 Days since retraction (latest)

Investigation on the mechanism of Ranunculus ternatus Thunb. against esophageal squamous cell carcinoma based on network pharmacology and experimental verification

Michen Deng, Yanhong Deng, Zu-gui Tang et al. (8 authors)

Research Square (Research Square) Open Access

Published: May 2024

1140 days after retraction

Phytochemical profile of Euphorbia hirta plant extract and its in vitro anticancer activity against the liver cancer HepG2 cells

Sengodan Kalaivani, Somannan Jayanthi, Kannan Revathi et al. (4 authors)

Vegetos

Published: Apr 2023
5 citations

760 days after retraction

Natural Products as Anticancer Agents: Current Status and Future Perspectives

Abid Naeem, Pengyi Hu, Ming Yang et al. (7 authors)

Molecules Open Access

Published: Nov 2022
295 citations

615 days after retraction

Phillygenin ameliorates nonalcoholic fatty liver disease via TFEB-mediated lysosome biogenesis and lipophagy

Wenling Zhou, Xu Yan, Yuanyuan Zhai et al. (8 authors)

Phytomedicine

Published: Jun 2022
34 citations

436 days after retraction

Brassinin inhibits proliferation and induces cell cycle arrest and apoptosis in nasopharyngeal cancer C666-1 cells

Weimin Yin, Xianbao Cao, Shen-Xiang Li et al. (5 authors)

Arabian Journal of Chemistry

Published: May 2022
6 citations

431 days after retraction

Comparative Evaluation of Forsythiae Fructus From Different Harvest Seasons and Regions by HPLC/NIR Analysis and Anti-inflammatory and Antioxidant Assays

Qian Qu, Yuefei Li, Qi Dong et al. (13 authors)

Frontiers in Pharmacology Open Access

Published: Nov 2021
7 citations

244 days after retraction

Procollagen‑lysine, 2‑oxoglutarate 5‑dioxygenase 1 increases cellular proliferation and colony formation capacity in lung cancer via activation of E2F transcription factor 1

Baijun Li, Hao Yang, Bin Shen et al. (5 authors)

Oncology Letters Open Access

Published: Oct 2021
9 citations

215 days after retraction

Oral Microbiota Variation: A Risk Factor for Development and Poor Prognosis of Esophageal Cancer

Xiaobo Song, Ole Kristian Greiner-Tollersrud, Huimin Zhou

Digestive Diseases and Sciences

Published: Sep 2021
10 citations

168 days after retraction

Phillygenin inhibits the inflammation and apoptosis of pulmonary epithelial cells by activating PPARγ signaling via downregulation of MMP8

Yu‐Feng Lin, Peng Yang

Molecular Medicine Reports Open Access

Published: Sep 2021
18 citations

165 days after retraction

Review on oxidative stress relation on COVID-19: Biomolecular and bioanalytical approach

Mehrnaz Ebrahimi, Parviz Norouzi, Hossein Aazami et al. (4 authors)

International Journal of Biological Macromolecules Open Access

Published: Aug 2021
32 citations

146 days after retraction

Ophiopogonin B induces reactive oxygen species‑dependent apoptosis through the Hippo pathway in nasopharyngeal carcinoma

Wenhui Dong, Qing Dong, Hairui Ding

Molecular Medicine Reports Open Access

Published: May 2021
13 citations

62 days after retraction

Therapeutic potential of AMPK signaling targeting in lung cancer: Advances, challenges and future prospects

Milad Ashrafizadeh, Sepideh Mirzaei, Kiavash Hushmandi et al. (11 authors)

Life Sciences

Published: May 2021
58 citations

60 days after retraction

Phillygenin Alleviates Lipopolysaccharide-Induced Acute Pneumonia by Modulating the Tumor Necrosis Factor α Signaling Pathway

Congjie Wang, Tan Yujun, Changjun Lv et al. (7 authors)

Research Square (Research Square) Open Access

Published: May 2021

43 days after retraction

Phillygenin protects against osteoarthritis by repressing inflammation via PI3K/Akt/NF-κB signaling: In vitro and vivo studies

Siqi Zhou, Haiyan Wen, Xiaotao Han et al. (4 authors)

Journal of Functional Foods Open Access

Published: Apr 2021
14 citations

8 days after retraction

Paper citing Phillygenin Exerts In Vitro and In Vivo Antitumor ...

Unknown Authors

Unknown Journal

Published: Mar 2021

Same day as retraction

A natural product phillygenin suppresses osteosarcoma growth and metastasis by regulating the SHP-1/JAK2/STAT3 signaling

Xiaomin Ding, Danqing Lu, Jianbo Fan

Bioscience Biotechnology and Biochemistry Open Access

Published: Jan 2021
14 citations

75 days before retraction

Role of NF-κB transcriptional factor activation during chronic fluoride intoxication in development of oxidative-nitrosative stress in rat’s gastric mucosa

O. Ye. Akimov, V.О. Kostenko

Journal of Trace Elements in Medicine and Biology

Published: Apr 2020
19 citations

340 days before retraction

<p>Phillygenin, a MELK Inhibitor, Inhibits Cell Survival and Epithelial–Mesenchymal Transition in Pancreatic Cancer Cells</p>

Hongchun Li, Miao Chen, Zhuying Yang et al. (10 authors)

OncoTargets and Therapy Open Access

Published: Apr 2020
19 citations

358 days before retraction

Targeting Cancer Metabolism to Resensitize Chemotherapy: Potential Development of Cancer Chemosensitizers from Traditional Chinese Medicines

Wei Guo, Hor‐Yue Tan, Feiyu Chen et al. (5 authors)

Cancers Open Access

Published: Feb 2020
54 citations

409 days before retraction

Modulation of Multiple Signaling Pathways of the Plant-Derived Natural Products in Cancer

Lirui Sun, Wei Zhou, Hongmei Zhang et al. (9 authors)

Frontiers in Oncology Open Access

Published: Nov 2019
78 citations

503 days before retraction

Phillygenin inhibits LPS-induced activation and inflammation of LX2 cells by TLR4/MyD88/NF-κB signaling pathway

Naihua Hu, Cheng Wang, Xuyang Dai et al. (8 authors)

Journal of Ethnopharmacology

Published: Nov 2019
122 citations

509 days before retraction

Quick Stats

Total Citations: 21

Years Since Retraction: 4.7 years

Open Access: Yes

Last Checked: Jul 24, 2025

Actions

More from this journal Similar subjects View Original Paper View Retraction Notice